Results 31 to 40 of about 3,556,677 (271)
659 Blocking cytokine IL-1 with anakinra for the prevention of cytokine release syndrome in COVID-19
Background: The novel coronavirus, known as SARS-CoV-2, or COVID-19 became a pandemic in early 2020, causing significant human suffering and economic woes globally.
Jason Williams +2 more
doaj +2 more sources
Сytokine release syndrome is the common complication of CAR-T therapy. We report a case of patient with B-cell acute lymphoblastic leukemia developing сytokine release syndrome with shock and multiple organ failure and requiring cytokine removal and ...
Antonina E. Shchekina +9 more
doaj +1 more source
Covid-19 Cytokine Release Syndrome and Drugs [PDF]
A survey of literature about the Cytokine Release Syndrome in Covid-19 and of some drugs used or proposed against ...
Sparavigna, Amelia Carolina +1 more
core +1 more source
Chimeric antigen receptor T (CAR-T) cell treatment is a rapidly emerging therapy for relapsed/refractory hematologic malignancies. Although cytokine release syndrome is a common complication, a concomitant development of biopsy-proven collapsing ...
Ratna Acharya +3 more
doaj +1 more source
Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy is an innovative therapeutic option for addressing certain recurrent or refractory hematological malignancies.
Puri Ferreros, Isabel Trapero
doaj +1 more source
Cytokine release syndrome in severe COVID-19 [PDF]
Lessons from arthritis and cell therapy in cancer patients point to therapy for severe ...
Moore, John B., June, Carl H.
openaire +2 more sources
Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions [PDF]
In October 2013, the International Life Sciences Institute - Health and Environmental Sciences Institute Immunotoxicology Technical Committee (ILSI-HESI ITC) held a one-day workshop entitled, “Workshop on Cytokine Release: State-of-the-Science, Current ...
Finco, D +14 more
core +1 more source
STAT: Cytokine Release Syndrome
Cytokine release syndrome is a systemic inflammatory condition that may occur after treatment with some types of immunotherapy.
openaire +3 more sources
COVID-19 cytokine storm: The anger of inflammation
Patients with COVID-19 who require ICU admission might have the cytokine storm. It is a state of out-of-control release of a variety of inflammatory cytokines. The molecular mechanism of the cytokine storm has not been explored extensively yet.
Keshavarz, Mohsen +4 more
core +1 more source
Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2 [PDF]
Blocking IL-6 pathways with sarilumab, a fully human anti-IL-6R antagonist may potentially curb the inflammatory storm of SARS-CoV2. In the present emergency scenario, we used "off-label" sarilumab in 5 elderly patients in life-threatening condition not ...
Jordi Casademont +26 more
core +1 more source

